| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Reimbursement from shareholder (note 10) | 162 | - |
| Net cash provided by (used in) financing activities | -6,618 | 459 |
| Increase in cash, cash equivalents and restricted cash | 8,724 | 5,940 |
| Cash and cash equivalents at end of period | 41,463 | - |
Xponential Fitness, Inc. (XPOF)
Xponential Fitness, Inc. (XPOF)